{"version":1,"type":"story","url":"https://digestai.news/story/do-we-need-the-largest-llms-for-every-clinical-decision","json":"https://digestai.news/story/do-we-need-the-largest-llms-for-every-clinical-decision.json","markdown":"https://digestai.news/story/do-we-need-the-largest-llms-for-every-clinical-decision.md","slug":"do-we-need-the-largest-llms-for-every-clinical-decision","headline":"Do We Need the Largest LLMs for Every Clinical Decision?","summary":"The authors present CERTA, a decision‑level statistical certificate that decides when a quantized model can replace its native BF16 reference for clinical verification. They evaluated eleven instruction‑tuned models, both general‑purpose and domain‑adapted, from three families (7-72B) on 2,500 clinical‑verification decisions drawn from de‑identified contexts of 2,484 patients, using patient‑disjoint calibration and testing.\n\nIn the operational analysis, round‑to‑nearest 8‑bit quantization at BF16 storage served 99.8‑100% of held‑out decisions across all eleven models. A class‑conditional 4‑bit frontier reduced the amortized BF16‑equivalent deployment cost to 25.8% for Qwen2.5-72B and 27.3% for HuatuoGPT-o1-72B, with measured peak memory of 43.0 and 42.7 GB, below the nominal capacity of a single 48 GB accelerator (deployment on that hardware was not directly tested). Under the exact split‑sample certificate, costs were 26.7% and 27.9%. On external disease named‑entity benchmarks, the frontier‑selected NF4 configurations showed a mean absolute F1 change of 0.045, indicating limited accuracy loss. CERTA thus turns compression choices into a risk‑controlled deployment policy for this verification task.","keyPoints":["CERTA enables 8-bit quantized models to handle 99.8‑100% of clinical verification decisions across eleven models.","4-bit quantization cuts deployment cost to about 25.8% and 27.3% of the BF16 reference for Qwen2.5-72B and HuatuoGPT-o1-72B, with peak memory ~43 GB.","Mean absolute F1 change on disease named‑entity benchmarks is 0.045, showing limited accuracy loss across models."],"whyItMatters":"Demonstrates that heavily quantized, cheaper models can safely replace large BF16 models for clinical decision support, lowering hardware costs and expanding deployment possibilities.","category":{"slug":"research","name":"Research","url":"https://digestai.news/category/research"},"entities":{"companies":[],"models":["Qwen2.5-72B","HuatuoGPT-o1-72B"],"people":[]},"firstPublishedAt":"2026-10-21T04:00:00Z","updatedAt":"2026-10-21T04:00:00Z","sourceCount":1,"hasPrimarySource":true,"sources":[{"outlet":"arXiv cs.CL","title":"Do We Need the Largest LLMs for Every Clinical Decision?","url":"https://arxiv.org/abs/2610.26937","publishedAt":"2026-10-21T04:00:00Z","type":"primary","primary":true,"lead":true}],"sourceNotes":null,"discussions":[],"thread":null,"cite":{"text":"Digest AI, \"Do We Need the Largest LLMs for Every Clinical Decision?\", 21 October 2026, https://digestai.news/story/do-we-need-the-largest-llms-for-every-clinical-decision","publisher":"Digest AI","title":"Do We Need the Largest LLMs for Every Clinical Decision?","datePublished":"2026-10-21T04:00:00Z","url":"https://digestai.news/story/do-we-need-the-largest-llms-for-every-clinical-decision"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}